前庭神经鞘瘤术后抑郁与工作能力:全国登记匹配队列研究
基于瑞典脑肿瘤登记库的全国性匹配队列研究,纳入333例组织病理学确诊的前庭神经鞘瘤手术患者及1662例匹配对照,比较术前2年与术后2年抗抑郁药、镇静药配药及病假模式。结果显示患者与对照抗抑郁药和镇静药使用率无显著差异,但术后2年患者无登记病假比例低于对照(75% vs 88%,p<0.01),术后长期病假可由镇静药使用、术前病假更多及术后新发神经功能缺损预测。
要点
- 前庭神经鞘瘤术后2年患者无病假比例低于匹配对照(75% vs 88%,p<0.01)。
- 抗抑郁药与镇静药使用率在患者与对照间术前及术后均无显著差异。
- 术后长期病假与镇静药使用、术前病假多及术后新发神经功能缺损相关。
核心结论
- 全国性匹配队列显示前庭神经鞘瘤患者与对照的抗抑郁药和镇静药使用率无显著差异,但术后病假率高于对照。
- 避免手术并发症和促进恢复正常职业生活对前庭神经鞘瘤术后患者具有重要性。
研究设计与样本
- 全国性登记库匹配队列研究,基于瑞典脑肿瘤登记库识别组织病理学确诊的前庭神经鞘瘤成人患者。
- 为每例患者匹配5例对照,共纳入333例患者和1662例匹配对照。
- 比较术前2年与术后2年抗抑郁药、镇静药配药模式及病假模式。
主要发现
- 术前2年抗抑郁药使用率患者6.0% vs 对照6.3%,术后2年10.1% vs 7.5%。
- 术前2年镇静药使用率患者3.9% vs 对照4.3%,术后2年4.8% vs 5.3%。
- 术后2年无登记病假比例患者75% vs 对照88%(p<0.01)。
- 术后长期病假预测因素:镇静药使用OR 0.60(95%CI 0.38-0.94,p=0.03),术前病假更多OR 0.91(95%CI 0.89-0.93,p<0.001),术后新发神经功能缺损OR 0.42(95%CI 0.24-0.76,p=0.004)。
临床怎么用
- 前庭神经鞘瘤术后应关注患者病假与复工情况,尤其是有镇静药使用、术前病假多或术后新发神经功能缺损者。
- 围手术期应重视避免手术并发症,以促进患者恢复正常职业生活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with vestibular schwannomas (VS), tumor control is often achieved, and life expectancy is relatively good. The main risks of surgical treatment are hearing loss and facial nerve function. The occurrence of mood and sleeping disorders in relation to surgery is an important aspect of health that has rarely been studied. Similarly, only limited data exist on the rate of sick leave for patients with VS. In this nationwide registry-based study, we define the use of antidepressants and sedatives and the sick leave pattern before and after VS surgery. METHODS: Adult patients with histopathologically verified VS were identified in the Swedish Brain Tumor Registry (SBTR) and clinical data were linked to relevant national registries after assigning five matched controls to each patient. We studied patterns of dispensed antidepressants and sedative drugs as well as patterns of sick leave compared to respective controls at 2 years before and 2 years following surgery. RESULTS: We identified 333 patients and 1662 matched controls. The rate of antidepressant use was similar between patients and controls 2 years before surgery (6.0% vs 6.3%) and 2 years after surgery (10.1% vs 7.5%). The rate of sedative use was also similar 2 years before surgery (3.9% vs 4.3%) and 2 years after surgery (4.8% vs 5.3%). The rate of sick leave was similar at baseline between patients and controls, but at 2 years after surgery, 75% of patients vs 88% of controls (p < 0.01) had no registered sick leave. Long-term sick leave after surgery was predicted by use of sedatives (OR 0.60, 95% CI 0.38-0.94, p = 0.03), more preoperative sick leave (OR 0.91, 95% CI 0.89-0.93, p < 0.001), and new-onset neurological deficits after surgery (OR 0.42, 95% CI 0.24-0.76, p = 0.004). CONCLUSION: This nationwide study shows no significant differences in the use of antidepressants and sedatives between patients and controls, while the rate of postoperative sick leave was higher in patients than in controls after VS surgery. Our findings underpin the importance of avoiding surgical sequelae and facilitating return to normal professional life.
引用
- Thurin E, Förander P, Bartek J, et al. Depression and ability to work after vestibular schwannoma surgery: a nationwide registry-based matched cohort study on antidepressants, sedatives, and sick leave. Acta Neurochir (Wien). 2021. PMID: 33963435. doi:10.1007/s00701-021-04862-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。